Lung cancer stage 4 Doctors Abroad — Page 5

Professor Sridhar P.S. is a senior radiation oncologist at HCG Manavata Cancer Centre who has performed over 2,500 CyberKnife procedures.

• Specialises in precise robotic radiosurgery for complex cases
• Awarded a Diplomate of the National Board in radiotherapy
• Focuses on hyperthermia oncology to improve treatment response
• Member of the Society for Neuro-Oncology
• Holds a Doctor of Medicine in radiotherapy from Banaras Hindu University

Professor Engin is a leading radiation oncologist who completed a post-doctoral fellowship in thermoradiotherapy at Thomas Jefferson University in the United States.

• Specialises in treating advanced-stage tumours using precise radiation delivery
• Director of Oncological Sciences at Medicana Bursa Hospital
• Former Chairman of Radiation Oncology at Uludağ University Medical College
• Received a research scholarship from the US National Cancer Institute (NCI)
• Expert in thermoradiotherapy, which uses heat to make cancer cells more sensitive to radiation

Associate Professor Abdullah Sakin is the former Head of Medical Oncology at Yüzüncü Yıl University, where he led the department in managing complex cancer cases.

• Specialises in medical oncology for advanced-stage tumours at Medipol Bahçelievler University Hospital
• Held senior clinical education roles at Prof Dr Cemil Taşçıoğlu City Hospital
• Former internal medicine specialist with deep expertise in managing systemic patient health during treatment
• Focuses on evidence-based protocols for patients with progressive respiratory malignancies

Professor Serdar Kalemci is a leading specialist in chest diseases at Ento Surgical Medical Center with a deep background in clinical research.

• Published 50 international studies on lung conditions and respiratory health
• Authored 40 research papers in prestigious SCI and SCI Expanded journals
• Specialises in managing complex cases and advanced-stage respiratory issues
• Recognised as a Professor for his academic and clinical contributions
• Presented research at numerous international medical congresses

Dr Chaitainya Borde has managed over 30,000 PET-CT scans – a critical tool for mapping the spread of advanced lung cancer. He leads the nuclear medicine services at the HCG Manavata Cancer Centre.

• Specialises in PET-CT imaging to track tumour activity and treatment response
• Performs Lu-177 radionuclide therapies – targeted radiation that treats cancer cells directly
• Provides nuclear cardiology services to monitor heart health during intensive cancer treatments
• Published research in medical journals focusing on nuclear medicine outcomes

Dr Shruti Kate is a specialist medical oncologist who previously served as a consultant at the world-renowned Tata Memorial Hospital. She focuses on personalized care for patients with advanced lung malignancies.

• Specialises in immunotherapy and metronomic therapy for stage 4 cases
• Recognised with a travel award at the World Conference on Lung Cancer
• Trained at Maulana Azad Medical College and Lady Hardinge Medical College
• Member of the International Association for the Study of Lung Cancer (IASLC)
• Expert in treating both solid tumours and haematological malignancies

Dr Shaunak Valame presented his research on gastrointestinal outcomes to the American Society of Clinical Oncology in San Francisco. He manages advanced cases at HCG Manavata Cancer Centre.

• Specialises in targeted therapies – drugs that attack specific cancer cells while sparing healthy tissue
• Trained in medical oncology at Indraprastha Apollo Hospital in New Delhi
• Focuses on the molecular basis of cancer to personalise treatment protocols
• Presented research at the International Winter School of Oncology at AIIMS
• Member of the American Society of Clinical Oncology (ASCO)

Professor Didem Tastekin is a multi-award-winning oncologist who leads medical oncology at Biruni University Hospital, specialising in complex, intensive cancer cases.

• Recognised as the 2018 Best Researcher of the Year at the Istanbul University Oncology Institute
• Received the TUBITAK Incentive Award for her contributions to cancer research
• Holds double residencies in internal medicine and medical oncology
• Active member of the American Society of Clinical Oncology (ASCO)
• Specialises in managing late-stage cases with tailored drug therapies